Thyroid disease in pregnancy management formalises around structured monitoring
Pregnancy-specific TSH targets, structured pre-conception thyroid management, and integrated maternal-fetal medicine and endocrinology pathways are reshaping thyroid disease in pregnancy.
Thyroid disease in pregnancy (hypothyroidism management with levothyroxine adjustment, hyperthyroidism management with PTU and methimazole choice by trimester, postpartum thyroiditis recognition) has been managed inconsistently. Pregnancy-specific TSH targets are now structured, pre-conception thyroid management for women with known thyroid disease is formalising, and integrated maternal-fetal medicine and endocrinology pathways are emerging. The screening-and-management infrastructure is the addressable-population enabler.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.